Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Sep-23 5:03 PM View:  | Seizinger Bernd R. Director | Aptose Biosciences Inc. (APTO) | 22-Sep-23 | Purchase | 17,000 | $3.14 | $53,380.00 | 100% 0 to 17.0K | |
| 23-Jan-23 7:57 PM View: | Payne Fletcher SR VP & Chief Fin. Officer | Aptose Biosciences Inc. (APTO) | 19-Jan-23 | Grant | 100,000 | -- | -- | 1000% 10.0K to 110.0K | |
| 23-Jan-23 7:50 PM View: | Bejar Rafael Sr. VP, Chief Medical Officer | Aptose Biosciences Inc. (APTO) | 19-Jan-23 | Grant | 100,000 | -- | -- | 1000% 10.0K to 110.0K | |
| 23-Jan-23 8:00 PM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 19-Jan-23 | Grant | 150,000 | -- | -- | 41% 363.25K to 513.25K | |
| 23-Jan-23 7:55 PM View: | Ledru Philippe Chief Commercial Officer | Aptose Biosciences Inc. (APTO) | 19-Jan-23 | Grant | 100,000 | -- | -- | 20000% 0.5K to 100.5K | |
| 21-Sep-22 6:07 PM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 19-Sep-22 | Private Purchase | 10,000 | $0.68 | $6,834.00 | 3% 353.25K to 363.25K | |
| 21-Sep-22 6:06 PM View: | Payne Fletcher SR VP & Chief Fin. Officer | Aptose Biosciences Inc. (APTO) | 19-Sep-22 | Private Purchase | 10,000 | $0.68 | $6,775.00 | 100% 0 to 10.0K | |
| 06-Jun-22 4:13 PM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 06-Jun-22 | Private Purchase | 10,000 | $0.97 | $9,681.00 | 3% 343.25K to 353.25K | |
| 21-Dec-21 11:19 AM View: | Burger Denis R Director | Aptose Biosciences Inc. (APTO) | 20-Dec-21 | Market Purchase | 10,000 | $1.45 | $14,490.00 | 46% 21.67K to 31.67K | (4%) |
| 17-Dec-21 1:38 PM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 16-Dec-21 | Market Purchase | 13,183 | $1.52 | $20,038.20 | 4% 330.07K to 343.25K | (3%) |
| 20-Dec-21 4:33 PM View: | Platzer Erich Director | Aptose Biosciences Inc. (APTO) | 16-Dec-21 | Market Purchase | 100,000 | $1.38 | $137,900.00 | 25% 405.0K to 505.0K | 9% |
| 15-Dec-21 1:48 PM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 15-Dec-21 | Market Purchase | 17,822 | $1.12 | $19,960.60 | 6% 312.25K to 330.07K | (< 1%) |
| 17-Dec-21 1:45 PM View: | Platzer Erich Director | Aptose Biosciences Inc. (APTO) | 15-Dec-21 | Market Purchase | 270,000 | $1.17 | $316,340.00 | 200% 135.0K to 405.0K | 25% |
| 29-Nov-21 11:53 AM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 26-Nov-21 | Market Purchase | 8,643 | $2.31 | $19,965.30 | 3% 303.6K to 312.25K | (1%) |
| 19-Nov-21 8:42 PM View: | Burger Denis R Director | Aptose Biosciences Inc. (APTO) | 19-Nov-21 | Option Exercise | 5,417 | $2.04 | $11,050.70 | 33% 16.25K to 21.67K | |
| 19-Nov-21 8:36 PM View: | Bejar Rafael Sr. VP, Chief Medical Officer | Aptose Biosciences Inc. (APTO) | 19-Nov-21 | Market Purchase | 10,000 | $2.56 | $25,600.00 | 100% 0 to 10.0K | (4%) |
| 06-Jul-21 5:07 PM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 02-Jul-21 | Market Purchase | 6,081 | $3.29 | $19,998.00 | 2% 297.52K to 303.6K | 2% |
| 23-Jun-21 5:08 PM View: | Whitehead Warren Director | Aptose Biosciences Inc. (APTO) | 22-Jun-21 | Market Sale | 9,600 | $3.24 | $31,104.00 | (39%) 24.6K to 15.0K | (2%) |
| 23-Jun-21 5:08 PM View: | Whitehead Warren Director | Aptose Biosciences Inc. (APTO) | 21-Jun-21 | Market Sale | 15,400 | $3.35 | $51,590.00 | (38%) 40.0K to 24.6K | 1% |
| 28-Dec-20 6:00 PM View: | Whitehead Warren Director | Aptose Biosciences Inc. (APTO) | 22-Dec-20 | Market Option Sale | 20,000 | $4.06 | $81,200.00 | (33%) 60.0K to 40.0K | |
| 28-Dec-20 6:00 PM View: | Whitehead Warren Director | Aptose Biosciences Inc. (APTO) | 22-Dec-20 | Option Exercise | 20,000 | $2.01 | $40,200.00 | 50% 40.0K to 60.0K | |
| 10-Jul-20 6:55 PM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 10-Jul-20 | Market Sale | 168,891 | $6.05 | $1,021,790.00 | (36%) 466.41K to 297.52K | 30% |
| 10-Jul-20 6:57 PM View: | Chow Gregory K. Executive VP & CFO | Aptose Biosciences Inc. (APTO) | 10-Jul-20 | Market Sale | 126,668 | $6.05 | $766,341.00 | (35%) 359.51K to 232.85K | 30% |
| 10-Jul-20 6:53 PM View: | Marango Jotin Senior VP, Chief Bus. Officer | Aptose Biosciences Inc. (APTO) | 10-Jul-20 | Market Sale | 62,835 | $6.05 | $380,152.00 | (35%) 179.05K to 116.22K | 30% |
| 02-Jul-20 8:08 PM View: | Marango Jotin Senior VP, Chief Bus. Officer | Aptose Biosciences Inc. (APTO) | 02-Jul-20 | Market Sale | 20,946 | $6.34 | $132,793.00 | (10%) 200.0K to 179.05K | 33% |
| 25-Jun-20 6:38 PM View: | Whitehead Warren Director | Aptose Biosciences Inc. (APTO) | 24-Jun-20 | Market Sale | 10,000 | $6.74 | $67,447.10 | (20%) 50.0K to 40.0K | 37% |
| 25-Jun-20 6:38 PM View: | Whitehead Warren Director | Aptose Biosciences Inc. (APTO) | 24-Jun-20 | Option Exercise | 12,000 | $1.94 | $23,300.00 | 27% 45.0K to 57.0K | |
| 25-Jun-20 6:38 PM View: | Whitehead Warren Director | Aptose Biosciences Inc. (APTO) | 24-Jun-20 | Market Option Sale | 7,000 | $6.74 | $47,212.90 | (12%) 57.0K to 50.0K | 37% |
| 25-Jun-20 6:38 PM View: | Whitehead Warren Director | Aptose Biosciences Inc. (APTO) | 23-Jun-20 | Market Option Sale | 18,000 | $7.11 | $127,890.00 | (29%) 63.0K to 45.0K | 40% |
| 25-Jun-20 6:38 PM View: | Whitehead Warren Director | Aptose Biosciences Inc. (APTO) | 23-Jun-20 | Option Exercise | 13,000 | $1.51 | $19,662.50 | 26% 50.0K to 63.0K | |
| 26-Mar-20 1:10 PM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 25-Mar-20 | Market Purchase | 3,400 | $5.82 | $19,803.00 | < 1% 463.01K to 466.41K | (27%) |
| 12-Mar-20 4:37 PM View: | Chow Gregory K. Executive VP & CFO | Aptose Biosciences Inc. (APTO) | 10-Mar-20 | Grant | 225,000 | -- | -- | 167% 134.51K to 359.51K | |
| 12-Mar-20 4:21 PM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 10-Mar-20 | Grant | 300,000 | -- | -- | 184% 163.01K to 463.01K | |
| 12-Mar-20 4:33 PM View: | Marango Jotin Senior VP, Chief Bus. Officer | Aptose Biosciences Inc. (APTO) | 10-Mar-20 | Grant | 120,000 | -- | -- | 150% 80.0K to 200.0K | |
| 28-Oct-19 1:59 PM View: | Rice William G. Chairman, President & CEO Director | Aptose Biosciences Inc. (APTO) | 24-Oct-19 | Market Purchase | 10,000 | $1.92 | $19,200.00 | 7% 153.01K to 163.01K | 123% |
| 07-Jun-19 2:03 PM View: | Chow Gregory K. Senior VP & CFO | Aptose Biosciences Inc. (APTO) | 05-Jun-19 | Market Purchase | 7,500 | $1.84 | $13,815.00 | 6% 127.01K to 134.51K | 133% |
| 05-Jun-19 1:21 PM View: | Marango Jotin Senior VP, Chief Bus. Officer | Aptose Biosciences Inc. (APTO) | 03-Jun-19 | Grant | 80,000 | -- | -- | 100% 0 to 80.0K | |
| 19-Apr-19 2:35 PM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 18-Apr-19 | Market Purchase | 10,000 | $1.85 | $18,507.00 | 7% 143.01K to 153.01K | 132% |
| 20-Mar-19 2:19 PM View: | Platzer Erich Director | Aptose Biosciences Inc. (APTO) | 19-Mar-19 | Market Sale | 20,000 | $2.19 | $43,805.00 | 17% 115.0K to 135.0K | 96% |
| 15-Mar-19 4:35 PM View: | Rice William G. Chair, President & CEO Director | Aptose Biosciences Inc. (APTO) | 14-Mar-19 | Market Purchase | 10,000 | $1.90 | $18,993.00 | 8% 133.01K to 143.01K | 126% |
| 14-Mar-19 5:32 PM View: | Chow Gregory K. Senior VP & CFO | Aptose Biosciences Inc. (APTO) | 13-Mar-19 | Market Purchase | 15,000 | $1.75 | $26,322.00 | 13% 112.01K to 127.01K | 145% |
